ALTIMMUNE, INC. Operating Lease Liability
ALTIMMUNE, INC. (ALT) had Operating Lease Liability of $1.40 million as of 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-06
- 2025-12-31: Operating Lease, Liability $1.40M.
- 2024-12-31: Operating Lease, Liability $1.68M.
- 2024-09-30: Operating Lease, Liability $1.77M.
- 2024-06-30: Operating Lease, Liability $1.86M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2025-12-31 | $1.40M 10-K · filed 2026-03-06 | |
| 2024-12-31 | $1.68M 10-K · filed 2025-02-27 | |
| 2024-09-30 | $1.77M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.86M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $552.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $671.00K 10-Q · filed 2024-05-09 | |
| 2023-09-30 | $788.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $903.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.01M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.12M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $1.23M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.33M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $1.44M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.53M 10-K · filed 2023-02-28 | $1.54M 10-K · filed 2022-03-15 |
| 2021-09-30 | $1.63M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.65M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $1.74M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.82M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $1.89M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.62M 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $1.68M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $1.74M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.80M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.86M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $1.92M 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |